针对线粒体ClpP:在癌症治疗中,ClpP激动剂的结构洞察力和治疗潜力
Mowei Kong1, Yang Yu1, Shuai Shao1
1Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Southwest Medical University, Luzhou, Sichuan, China.
Oncology reviews
|May 21, 2025
概括
线粒体ClpP蛋白酶在癌细胞中过度表达,使其成为有前途的药物标. 激活ClpP为癌症治疗提供了一个新的治疗策略.
科学领域:
- 线粒体生物学 线粒体生物学
- 在瘤学瘤学.
- 药物发现 药物发现
背景情况:
- 线粒体对细胞能量和新陈代谢至关重要;它们的功能障碍与癌症等疾病有关.
- 线粒体血清蛋白酶ClpP,与其辅导体ClpX,通过降解受损蛋白质来维持线粒体的完整性.
- ClpP因其在各种癌症类型中的过度表达而越来越受认可,将其定位为潜在的治疗标.
研究的目的:
- 审查线粒体ClpP在癌症中的结构,生理作用和治疗潜力.
- 探索使用ClpP激动剂作为抗癌剂的机制基础.
- 讨论开发选择性人类ClpP激活剂的挑战.
主要方法:
- 关于线粒体ClpP的当前研究的文献综述.
- 分析ClpP在细胞信号传递和蛋白质降解中的作用.
- 对ClpP激动剂的药物开发策略的检查.
主要成果:
- 在癌症中ClpP的过度表达表明其参与瘤发生.
- 作为一种新型的抗癌药物,ClpP激活剂显示出有前途的前景.
- 开发针对人类ClpP的选择性小分子存在重大挑战.
结论:
- 线粒体ClpP代表了癌症治疗的未经探索的目标.
- 准ClpP为癌症治疗提供了一个新的治疗途径.
- 需要进一步的研究,以克服开发特定的ClpP激活药物的挑战.
相关概念视频
Electron Transport Chain: Complex I and II
9.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Mitochondria
9.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.3K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


